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Abstract 
 
Background: Morin is a flavanoid which exhibits potent antioxidant activity in various oxidative stress related 
diseases. The current study was attempted to scrutinize the preclinical bio-efficacy of morin on focal ischemia.  
Methods: The animal model of focal cerebral ischemic injury was done by midbrain carotid artery occlusion (MCAO) 
method, followed by Morin (30mg/kg) administration for seven days.  
Results: The outcome of the study showed that treatment with morin displayed positive effects in reducing the focal 
cerebral ischemia. This effect was evident with the improvements in neurological deficits, reduction in MDA content 
and elevation of antioxidant levels (SOD, GSH and Gpx). Furthermore, protein expression of Bax and caspase-3 were 
effectively down-regulated, whilst the expression of Bcl-2 was significantly elevated. On the other hand, the mRNA 
expression of proinflammatory cytokines was significantly reduced in focal cerebral ischemic rats upon morin 
intervention.  
Conclusion:  Thus, the beneficial effects of morin on cerebral ischemia assault may result from the reduction of 
oxidative stress, inhibition of apoptosis and inflammation. The neuroprotective effects of morin supplement may serve 
as potent adjuvant in the amelioration of ischemic stroke. 
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Introduction 
 
Globally, stroke is the prominent element of fatality and cardinal factor in the adult disability. The swift 
obstruction of blood flow mediated by thrombus or embolism elicits an ischemic status in many of the stroke patients 
(Donnan et al., 2008; Lakhan et al., 2009). Albeit, tissue plasminogen activator is available for stroke treatment, it 
elicits minimal therapeutic window and efficacy (Hacke et al., 2008; Zhang et al., 2011). Thus, an effective clinical 
moiety for the amelioration of stroke is highly essential. Earlier, research studies underscore that, array of biological 
mechanism such as deprivation of ionic status, loss of ATP, rampant release of excitatory neurochemical transmitters, 
increased generation of reactive oxygen species (ROS) and apoptosis are the mainstay in the pathology of cerebral 
ischemic damage (Durukan and Tatlisumak, 2007; Lapchak and Araujo, 2007). Further, the above mentioned toxic 
events may aggravate to form irreversible brain damage. 
In cerebral ischemia, oxidative stress is the predominant condition in the destruction of neuronal cell viability 
and tissue damage (Chan, 1996; Chen et al., 2011). During oxidative assault, vital bio molecules like DNA, lipids and 
protein will be affected by rampant release of free radicals and cause cell injury.  
The prime noxious process during the tissue damage provoked by cerebral ischemia is mainly mediated by apoptosis 
induced DNA damage (Kawaguchi, et al., 2004; Liu et al., 2008; Wang et al., 2010; Lu et al., 2010). During cerebral 
ischemia, exorbitant oxidative stress status triggers the release of cytochrome C from mitochondria which overture to 
Caspase-3 activation (Broughton et al., 2009). Further, the released cytochrome c initiates the formation of apoptosome 
complex which encompasses apoptotic-protease activating factor- 1, procaspase-9 and ATP (Wang, 2001). Then the 
apoptosome act as an activator of procaspase-9 initially and then procaspase-3 (Li et al., 1997). Thus, in the apoptotic 
cascade, the caspase-3 in its activated form regulates the process of DNA fragmentation leading to cell damage 
(Broughton et al., 2009). 
The Bcl-2 family related genes are chiefly implicated in the regulation of apoptotic process by 
activation/inactivation of protein systems (Elmore, 2007). The Bcl-2 protein blocks the apoptosis process in various 
cell systems involved in the antithetic regulation proapoptotic factors overexpression (Gross et al., 1999; Shigeomi et 
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al., 1999). The proapoptotic protein Bax integrates pivotal functions in inducing apoptosis (Yi-Te et al., 1997; Martinou 
et al., 2011). 
Inflammation of cerebral cortex is the crucial scenario in the progression of ischemic stroke (Amantea et al., 2009; 
Kleinig and Vink, 2009). Mammoth reports, indicate that during cerebral ischemia there is an accelerated elevation in 
the levels of cytokines such as, TNF-α, IL-1β and IL-6 (Wang et al., 2007; del Zoppo et al., 2000).In this context, 
agents which can limit ROS formation have been implicated to ameliorate brain damage following stroke-like events. 
Recently, plant derived flavanoid molecules gaining more attention for the mitigation of oxidative stress mediated 
pathologies. In this scenario, Morin a natural flavanoid ingredient found in wide array of Chinese medicinal plant 
displays potential anti-inflammatory and antioxidant activity (Wang et al., 2006). The neuroprotective effect of morin 
have been reported in Parkinsonism disease model (Zhang et al., 2010), however its beneficial effect on cerebral 
ischemia mediated neurotoxicity is not reported till date. Hence, we investigated neuroprotective efficacy of morin in 
alleviating cerebral ischemic insult in a murine model of middle cerebral artery occlusion (MCAO).  
 
Materials and Methods 
Drugs and Chemicals  
 
Morin (≥ 98 %) was procured form Sigma Aldrich, USA. All other chemicals and reagents used in the study 
were analytical grade. 
 
Animals 
 
Male Adult Sprague-Dawley rats, aged 12-14 weeks and weighing 160- 200 g were accessed from the 
Binzhou City Central Hospital, Binzhou, Shandong, China. The animals were housed in well maintained concrete 
structures with specified laboratory and humidity conditions under 12-h light/12-h dark cycles.  
The rats were randomly divided into 3 groups and each group consists of 10 rats. The grouping of animals were as 
follows,  
Group 1- Sham rats were given anaesthesia by 10% chloral hydrate (350mg/kg; b.wt; i.p) and carotid artery was 
exposed but did not undergo MCAO surgery. 
Group 2- MCAO operated groups were treated with normal saline.  
Group 3-MCAO groups were administered with Morin (30 mg/kg b.wt) through oral route.  The Morin treatment was 
carried out for seven days daily after MCAO.  
 
Animal model of MCAO 
 
The MCAO mediated transient cerebral ischemia focal cerebral ischemic injury was induced by intraluminal 
filament surgical procedure (Longa et al., 1989). Anaesthesia of rats was done by intra peritoneal administration of 
10% chloral hydrate (350mg/kg; b.wt). Briefly the right carotid artery was exposed, and a sterile nylon thread (15 mm 
length and 0.15 mm in diameter) was inserted into from the external to internal carotid artery and thus the origin of the 
left middle cerebral artery (MCA) was occluded. The procedure was terminated when mild resistance was felt.  
 
Neurological test 
 
The neurological deficts evaluation was done at 24 hours after MCAO surgery. The scoring was done by the 
method of Garcia et al (1995). The behavioural parameters like spontaneous action, equilibrium movement of fore 
limbs, stretching of fore paw, climbing, body voluntary movements, and response to vibrissae touch were measured. 
The scoring for the six tests was   done from 0 to 3. The score ranges from a minimum score of 0 to a maximum of 18.  
The minimal score depicts serious neurological deficits.  
 
Evaluation of oxidative stress 
 
Briefly, the cortex affected with ischemia (n = 7) were homogenized in ice-chilled Tris buffer (pH 7.4). Then 
the homogenate was centrifuged at 12,000 X rpm at 4°C for 15 min. Then the resultant supernatant was separated to 
evaluate the malodialdehyde (MDA) level, superoxide dismutase (SOD) and glutathione peroxidase (GPx)  content and 
activity of reduced glutathione (GSH) by spectrophotometer as per the instructions provided by the assay kit (Nanjing 
Jiancheng, China). 
 
Measurement of apoptotic protein using Western blot analysis 
 
Cortex affected with ischemia (n = 3, for each group) were isolated and homogenized in ice cold RIPA buffer 
(Applygen Technologies Inc., China). Then 20µg of protein samples were set on by 10% sodium dodecyl sulphate 
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polyacrylamide gel electrophoresis (SDS-PAGE) for apoptotic proteins Caspase-3, Bax, and Bcl-2. The respective 
primary antibodies used in the analysis were, Caspase-3,1:1,000; Bax, 1:1,000; Bcl-2, 1:750 (Proteintech Group, USA). 
The blot was freed from unbounded primary antibodies and incubated with goat anti-mouse IgG conjugated to 
peroxidase (Santa Cruz, USA). β- actin (1:5,000, Santa Cruz, USA) used as an internal control. The binding of antibody 
was detected by ECL detection kit (Applygen Technologies Inc, China) and the protein bands were visualized using 
Gel Doc XR system (Bio-Rad, USA) 
 
Analysis of pro-inflammatory cytokine gene expression by RT-PCR 
 
From the frozen samples of rat ischemic cortex, the RNA was isolated and purified using the protocol 
provided in the kit (TRIzol, Gibco). The cDNAs was prepared from 1 µg of the purified RNA sample. The primers 
used for the RT-PCT analysis  were shown in Table 1.The reaction was done for 30 cycles at using the following steps: 
30s denaturing at 95 °C followed by a 30-sannealing step at 57 °C. Finally, the extension step was carried out for 1 min 
at 72 °C. The band intensity measurement was done by computerized image analysis procedure (Motic Images 
Advanced 3.2). 
Table 1: Primer used in the RT-PCR study 
 
 
 
 
 
 
 
 
 
Statistical Analysis 
 
The data were shown as mean ± S.E.M. The data analysis was done by using SPSS v 13.0.  All data were 
subjected to one-way ANOVA and the comparison between the groups was dome by Tukey’s test. The value of P < 
0.05 was considered as statistically significant. 
 
Results 
Morin improved the neuro behavorial score provoked by cerebral ischemia 
 
The neurological score was diminished significantly (p< 0.05) in the MCAO animals as compared to the sham 
operated groups. After Morin treatment, neurological deficits were reduced compared to that of the MCAO (p< 0.05). 
The sham operated rats doesn’t elicited any evidence of neurological deficit (Fig 1). 
 
 
Figure 1: Morin improved the neuro behavorial score provoked by cerebral ischemia. The neurological assessment was 
done by 18 point Garcia scale system. The results were shown as mean ±SEM for 10 rats in each group. Comparisons 
are made between: (a) Sham and MCAO; (b) MCAO + Morin. *Statistically significant (p<0.05). 
 
S/No Gene Primer Sequence 
   
1 
 
2 
 
3 
TNF-α 
 
IL-6 
 
β-actin 
Forward:5′-ATGAGCACGGAAAGCATGATCCGA-3′ 
Reverse: 5′-CCAAAGTAGACCTGCCCGGACTC-3′  
Forward:5′-CCAGTTGCCTTCTTGGGACTGATG-3′ 
Reverse:5′-ATTTTCTGACCACAGTGAGGAATG-3′  
Forward:5′ GCA CCA CAC CTT CTA CAA TG  -3′  
Reverse: 5′-TGC TTG CTG ATC CAC ATC TG-3′ 
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Morin significantly attenuated the lipid peroxidation in MCAO rats  
 
Lipid peroxidation in the ischemic hemisphere was analysed by estimating the level of MDA (Fig. 2). In 
MCAO rats, the MDA value was significantly (p < 0.05) elevated as that of the sham rats. Thus, the elevated MDA 
level reflects the state of oxidative stress in MCAO rats, which was effectively reduced by Morin intervention (p < 
0.05). 
 
Figure 2: Morin significantly attenuated the lipid peroxidation in MCAO rats. MDA serves as a prominent marker of 
lipid peroxidation and it is expressed in terms of nmole/mg tissue. The results were shown as mean ±SEM for 7 rats in 
each group. Comparisons are made between: (a) Sham and MCAO; (b) MCAO and MCAO +Morin *Statistically 
significant (p<0.05). 
 
Morin boosted the antioxidant level in cerebral ischemia rats 
 
In the present study, post MCAO there was a significant (p < 0.05) decline in the level of antioxidants (GSH, 
SOD and Gpx) when compared to the sham rats. Morin intervention significantly (p < 0.05) elevated the level of 
antioxidant in brain through its anti lipid peroxidative effect (Fig 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Morin boosted the antioxidant level in cerebral ischemia rats. (A): SOD (U/mg protein); (B) Gpx (U/mg 
protein); (C) GSH (µg/mg protein). The results were shown as mean ±SEM for 7 animals in each group. Comparisons 
are made between: (a) Sham and MCAO; (b) MCAO and MCAO +Morin. *Statistically significant (p<0.05). 
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Influence of Morin and MCAO on apoptotic protein markers assessed by Western Blot 
 
The protein expression of apoptotic markers Caspase-3, Bax and Bcl-2 in cortex tissues affected with ischemia 
was done by Western blot. There was a significant upregulation of protein expression of Caspase-3 and Bax and 
downregulation of Bcl-2 protein expression in ischemic group. However, Morin treated rats displayed significant 
downregulation of Caspase-3 and Bax and upregulation of Bcl-2 protein expression (Fig 4A). Further, the relative 
protein expression of apoptotic markers (Bcl-2, Bax and Caspase-3) were significantly (p<0.05) altered in MCAO 
group as that of the control and Morin administered rats elicited effective restoration in the expression level apoptotic 
proteins (Fig 4B, 4C & 4D). 
 
Morin inhibited the cytokine mRNA expression profile in MCAO rats 
 
In the present study, MCAO rats displayed significant upregulated mRNA gene expression of 
proinflammatory cytokines (TNF-α and IL-6) and Morin treated rats significantly attenuated the inflammation by 
downregulating the mRNA expression of TNF-α and IL-6 (Fig 5A). Further, the relative expression of TNF-α and IL-6 
were significantly (p<0.05) higher in the MCAO group as that of the control and Morin intervention elicited significant 
(p<0.05) reduction in the expression level of proinflammatory cytokines (Fig 5B). 
 
 
 
 
Figure 4: Influence of Morin on Apoptosis-Related Protein after Cerebral Ischemic injury assessed by Western Blot. 
Β-actin served as a standard. (A) MCAO injured rats displayed upregulated expression of Bax and caspase- 3, whilst 
the expression of Bcl-2 was decreased. Morin significantly attenuated the apoptosis and restored the markers level to 
normalcy. The Relative protein expression levels were shown as (B) Caspase-3; (C) Bax and (D) Bcl-2. The results 
were shown as mean ±SEM for 3 rats in each group. Comparisons are made between: (a) Sham and MCAO; (b) MCAO 
and MCAO +Morin *Statistically significant (p<0.05). 
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Figure 5: Morin inhibited the cytokine mRNA expression profile in MCAO rats. β-actin served as a standard. (A) After 
MCAO the upregulated mRNA expression of TNF-α and IL-6 was observed and Morin treatment effectively reduced 
the expression. (B) Relative mRNA level of TNF-α and IL-6. Values are mean ±SD for 3 rats in each group. 
Comparisons are made between: (a) Sham and MCAO; (b) MCAO and MCAO +Morin.*Statistically significant 
(p<0.05). 
 
 
The preclinical MCAO model performed insertion of thread is the most widely used stroke model, since the 
pathological features closely resembles the conditions in stroke patients affected from focal cerebral arterial thrombosis 
(Longa et al., 1989).  The restriction of blood flow to brain during ischemic conditions may exaggerate the necrosis of 
neuronal and brain cells (Traystman, 2003; Park et al., 2009). Array of bio mechanisms like elevated level of ROS, 
reduced state of detoxification cascade and blockade of antioxidant reserve enzymes have been involved in the 
pathology of cerebral ischemia (Kutsuna et al., 2010; Pratap et al., 2011). The present study is focused to delineate the 
neuroprotective role of Morin on focal cerebral ischemic injury.
 
In our study, MCAO rats displayed significant reduction in the voluntary motor activity and the flexion tests 
and affects the behavioural activity. Thus, the neurological deficts in ischemia conditions is mainly due to excessive 
free radical generation in hippocampus and cortical areas responsible for motor activities (Nakamura et al., 2004). 
However, Morin administration significantly attenuated the neurological deficts, restored the brain motor activities 
which is in corroboration with the previous report (Zhang et al., 2010).  
The free radicals released during cerebral ischemia vulnerably oxidize the biomolecules like lipids which 
further exasperate cell toxicity and brain dysfunction (Akinmoladun et al., 2015). The noxious effects of free radical on 
lipids prelude to the formation of lipid peroxidation end product, MDA, a toxic product which educe neuronal cell 
death and loss of brain function (Serteser et al., 2002).  In our study, Morin treatment reduced the MDA level in 
MCAO rats, which is highly attributed to inhibitory potential of Morin on the oxidative insult (Subash and 
Subramanian, 2009).  GSH, an effective non-protein thiol, act as potent quencher of ROS. Previous research studies 
indicate that cerebral ischemia induced lipid peroxidation is concurrent with GSH depletion in brain tissue (Chan, 
2001; Al-Omar et al., 2006; Saleem et al., 2006). Further, studies reveal that antioxidant enzymes like SOD and GPx 
mediate pivotal function a prime role in the regulation of redox homeostasis in tissues (Gilgun-Sherki et al., 2002; Lo et 
al., 2003). In the present study, MCAO groups displayed reduced level of GSH, SOD and GPx in the brain ischemic 
tissue.  Treatment with Morin restored the depleted antioxidants level due to its potent antioxidant action and anti lipid 
peroxidative effect. The occurrence of a phenolic group with an aromatic base conjugation in the structure of morin 
contributes to the reduction of ROS (Wang et al., 2006; Hou et al., 2003). 
The TNF-α and IL-1β levels, as a result of inflammation were considerably elevated during ischemic stroke 
and also augment the process of brain damage in ischemic conditions (Hallenbeck,2002; Rothwell et al., 1997). 
Further, the elevated level of proinflammatory cytokines increases the protein level of ICAM-1 and E-selectin in 
leukocytes, and enhances the adhesion and transendothelial migration of leukocytes. Finally, these mechanisms, 
activates the inflammatory cascade damage of BBB, edema in brain and neuronal cell death (Huang et al., 2006). In our 
study MCAO rats displayed upregulation of TNF-α and IL-1β mRNA expression in ischemic brain tissue. The reports 
highlighted in the present study are in corroboration with the previous reports that aggravated TNF-α and IL-1β levels 
are one of the cardinal factors in brain damage after transient brain ischemia
 
(Tang et al., 2010). However, Morin 
intervention effectively downregulated the expression of proinflammatory cytokines mediated through its anti-
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inflammatory activity (Fang et al., 2003; Galvez et al., 2001; Lee et al., 2008). Apoptosis mediate a central role in the 
progression of cerebral ischemia injury through activation apoptotic related protein cascade located within the apoptotic 
cells (Galluzzi et al., 2009; Nakka et al., 2008). The Bcl-2 family related proteins are the mainstay in the regulation of 
major apoptotic signal transduction pathways and elicit irreversible cell damage (Weyhenmeyer et al., 2012; Yang et 
al., 2009).  The Bcl-2/Bax ratio is the hallmark in the process of apoptotic cell death (Bar-Am et al., 2004). 
Furthermore, Caspase-3, is the key protein involved in the apoptosis, which is highly vital for DNA damage and the 
noxious cell morphology alteration in relation to apoptosis (Cohen, 1997; Janicke et al., 1998). In our study, MCAO 
rats displayed upregulated protein expression of Caspase 3, Bax and downregulated protein level of Bcl-2 in ischemic 
tissue of brain. Whilst, the morin intervention restored the expression of apoptotic markers to normal and thus 
prevented the apoptosis. The anti-apoptotic activity of Morin is documented in the previous research reports (Poonam 
and Radhika, 2012). Further in our study, no negative effect of morin has been documented and receptor based studies 
and molecular level studies are cardinal to study the negative effect of morin. 
 
Conclusion 
 
The outcome of the current study shows that the neuro-protection rendered by Morin on cerebral ischemic 
damage provoked by MCAO rats mainly due to inhibition of neurological deficits and lipid peroxidation, restoration of 
antioxidants followed by the mitigation of inflammation and apoptosis responses. Thus, based on the preclinical results 
Morin may be a suitable clinical molecule for the amelioration of array of brain ischemic conditions as a result of 
oxidative damage. Furthermore, molecular mechanism research studies are highly warranted to explore the anti-stroke 
efficacy of Morin.  
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